These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 30264435

  • 1. Protective role of c-Jun N-terminal kinase-2 (JNK2) in ibuprofen-induced acute liver injury.
    Zoubek ME, Woitok MM, Sydor S, Nelson LJ, Bechmann LP, Lucena MI, Andrade RJ, Bast A, Koek GH, Trautwein C, Cubero FJ.
    J Pathol; 2019 Jan; 247(1):110-122. PubMed ID: 30264435
    [Abstract] [Full Text] [Related]

  • 2. Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.
    Cubero FJ, Zoubek ME, Hu W, Peng J, Zhao G, Nevzorova YA, Al Masaoudi M, Bechmann LP, Boekschoten MV, Muller M, Preisinger C, Gassler N, Canbay AE, Luedde T, Davis RJ, Liedtke C, Trautwein C.
    Gastroenterology; 2016 Apr; 150(4):968-81. PubMed ID: 26708719
    [Abstract] [Full Text] [Related]

  • 3. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
    Kodama Y, Taura K, Miura K, Schnabl B, Osawa Y, Brenner DA.
    Gastroenterology; 2009 Apr; 136(4):1423-34. PubMed ID: 19249395
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway.
    Wang Y, Singh R, Lefkowitch JH, Rigoli RM, Czaja MJ.
    J Biol Chem; 2006 Jun 02; 281(22):15258-67. PubMed ID: 16571730
    [Abstract] [Full Text] [Related]

  • 5. Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP.
    Schattenberg JM, Nagel M, Kim YO, Kohl T, Wörns MA, Zimmermann T, Schad A, Longerich T, Schuppan D, He YW, Galle PR, Schuchmann M.
    Am J Physiol Gastrointest Liver Physiol; 2012 Aug 15; 303(4):G498-506. PubMed ID: 22700824
    [Abstract] [Full Text] [Related]

  • 6. Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation.
    Nakagawa H, Maeda S, Hikiba Y, Ohmae T, Shibata W, Yanai A, Sakamoto K, Ogura K, Noguchi T, Karin M, Ichijo H, Omata M.
    Gastroenterology; 2008 Oct 15; 135(4):1311-21. PubMed ID: 18700144
    [Abstract] [Full Text] [Related]

  • 7. Hepatotoxicity mediated by pyrazole (cytochrome P450 2E1) plus tumor necrosis factor alpha treatment occurs in c-Jun N-terminal kinase 2-/- but not in c-Jun N-terminal kinase 1-/- mice.
    Wang X, Wu D, Yang L, Cederbaum AI.
    Hepatology; 2011 Nov 15; 54(5):1753-66. PubMed ID: 21748763
    [Abstract] [Full Text] [Related]

  • 8. Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma.
    Cubero FJ, Mohamed MR, Woitok MM, Zhao G, Hatting M, Nevzorova YA, Chen C, Haybaeck J, de Bruin A, Avila MA, Boekschoten MV, Davis RJ, Trautwein C.
    Hepatol Commun; 2020 Jun 15; 4(6):834-851. PubMed ID: 32490320
    [Abstract] [Full Text] [Related]

  • 9. Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure.
    Henderson NC, Pollock KJ, Frew J, Mackinnon AC, Flavell RA, Davis RJ, Sethi T, Simpson KJ.
    Gut; 2007 Jul 15; 56(7):982-90. PubMed ID: 17185352
    [Abstract] [Full Text] [Related]

  • 10. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.
    Kodama Y, Kisseleva T, Iwaisako K, Miura K, Taura K, De Minicis S, Osterreicher CH, Schnabl B, Seki E, Brenner DA.
    Gastroenterology; 2009 Oct 15; 137(4):1467-1477.e5. PubMed ID: 19549522
    [Abstract] [Full Text] [Related]

  • 11. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
    Liu J, Minemoto Y, Lin A.
    Mol Cell Biol; 2004 Dec 15; 24(24):10844-56. PubMed ID: 15572687
    [Abstract] [Full Text] [Related]

  • 12. c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets.
    Varona-Santos JL, Pileggi A, Molano RD, Sanabria NY, Ijaz A, Atsushi M, Ichii H, Pastori RL, Inverardi L, Ricordi C, Fornoni A.
    Diabetologia; 2008 Dec 15; 51(12):2271-80. PubMed ID: 18853132
    [Abstract] [Full Text] [Related]

  • 13. Isoform-specific functions of c-Jun N-terminal kinase 1 and 2 in lung ischemia-reperfusion injury through the c-Jun/activator protein-1 pathway.
    Tan J, Gao W, Yang W, Zeng X, Wang L, Cui X.
    J Thorac Cardiovasc Surg; 2021 Aug 15; 162(2):e143-e156. PubMed ID: 32414595
    [Abstract] [Full Text] [Related]

  • 14. JNKs protect from cholestatic liver disease progression by modulating Apelin signalling.
    Mohamed MR, Haybaeck J, Wu H, Su H, Bartneck M, Lin C, Boekschoten MV, Boor P, Goeppert B, Rupp C, Strnad P, Davis RJ, Cubero FJ, Trautwein C.
    JHEP Rep; 2023 Nov 15; 5(11):100854. PubMed ID: 37791376
    [Abstract] [Full Text] [Related]

  • 15. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
    Gancz D, Donin N, Fishelson Z.
    Mol Immunol; 2009 Dec 15; 47(2-3):310-7. PubMed ID: 19864026
    [Abstract] [Full Text] [Related]

  • 16. c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity.
    Gunawan BK, Liu ZX, Han D, Hanawa N, Gaarde WA, Kaplowitz N.
    Gastroenterology; 2006 Jul 15; 131(1):165-78. PubMed ID: 16831600
    [Abstract] [Full Text] [Related]

  • 17. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent.
    Gan LT, Van Rooyen DM, Koina ME, McCuskey RS, Teoh NC, Farrell GC.
    J Hepatol; 2014 Dec 15; 61(6):1376-84. PubMed ID: 25064435
    [Abstract] [Full Text] [Related]

  • 18. Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha.
    Kosters A, White DD, Sun H, Thevananther S, Karpen SJ.
    J Hepatol; 2009 Nov 15; 51(5):898-908. PubMed ID: 19767119
    [Abstract] [Full Text] [Related]

  • 19. Haematopoietic cell-derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury.
    Cubero FJ, Zhao G, Nevzorova YA, Hatting M, Al Masaoudi M, Verdier J, Peng J, Schaefer FM, Hermanns N, Boekschoten MV, Grouls C, Gassler N, Kiessling F, Muller M, Davis RJ, Liedtke C, Trautwein C.
    J Hepatol; 2015 Jan 15; 62(1):140-9. PubMed ID: 25173965
    [Abstract] [Full Text] [Related]

  • 20. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
    Babaev VR, Yeung M, Erbay E, Ding L, Zhang Y, May JM, Fazio S, Hotamisligil GS, Linton MF.
    Arterioscler Thromb Vasc Biol; 2016 Jun 15; 36(6):1122-31. PubMed ID: 27102962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.